$Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies$

Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2012-07, Vol.26 (7), p.1686-1689
Hauptverfasser:	Giles, F J, Vey, N, Rizzieri, D, Ravandi, F, Prebet, T, Borthakur, G, Jacobsen, T F, Hagen, S, Nilsson, B, O'Brien, S
Format:	Artikel
Sprache:	eng
Schlagworte:	631/92/436/1729 692/699/67/1990 Adult Autoimmune diseases Biological and medical sciences Cancer Research Critical Care Medicine Cytarabine Cytarabine - analogs & derivatives Cytarabine - blood Cytarabine - pharmacokinetics Cytarabine - therapeutic use Dosage and administration Drug dosages Drug therapy Endometriosis Hematologic and hematopoietic diseases Hematologic Neoplasms - drug therapy Hematology Humans Intensive Internal Medicine letter-to-the-editor Letters to the editor Leukemia Medical sciences Medicine Medicine & Public Health Middle Aged Oncology Patients Pharmacokinetics Prognosis Regression (Disease) Thrombocytopenia Tissue Distribution Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0887-6924 1476-5551
DOI:	10.1038/leu.2012.1